Registration Fees 

Please choose your ticket type and renew your CSHG membership during the registration process accordingly.
Become a member of the CSHG and save on your conference registration fee!

  • 1-year employee membership for €30
  • 2-year employee membership for €50
  • 1-year student membership for €15
  • 2-year student membership for €25
  • Non-members conference participation €40

Important Dates

  • October 7th 2025
    Abstract submission deadline
  • October 10th 2025
    Selected Abstracts announcement
  • October 24th 2025
    Conference Registration deadline
  • October 30th 2025
    CSHG Membership renewal

Quick Links

Photo Gallery

Welcome Address CSHG, Marios Ioannides, President of the Cyprus Society of Human Genetics
Welcome Address CSHG, Marios Ioannides, President of the Cyprus Society of Human Genetics
Welcome Address, Ministry of Health, Ms Natasa Anastasiadou (representative)
Welcome Address, Ministry of Health, Ms Natasa Anastasiadou (representative)
Best Oral Presentation Award presented to Ioannis Livanos (PhD candidate), Neurogenetics Department, The Cyprus Institute of Neurology and Genetics
Best Oral Presentation Award presented to Ioannis Livanos (PhD candidate), Neurogenetics Department, The Cyprus Institute of Neurology and Genetics
Best Poster Presentation Award presented to Dr Nikoletta Y. Papaioannou, Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus
Best Poster Presentation Award presented to Dr Nikoletta Y. Papaioannou, Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus
The Genome of Europe: Towards using Genetic Information in Health Care and Prevention, Prof André Uitterlinden, Erasmus University Medical Center
The Genome of Europe: Towards using Genetic Information in Health Care and Prevention, Prof André Uitterlinden, Erasmus University Medical Center
Driving the multiomics revolution, the latest innovations from illumina, Illumina representative, Scientronics Ltd (distributor)
Driving the multiomics revolution, the latest innovations from illumina, Illumina representative, Scientronics Ltd (distributor)
Rapid NGS testing in medical research, Thermo Scientific Representative, C.Georgiou Lab Supplies (distributor)
Rapid NGS testing in medical research, Thermo Scientific Representative, C.Georgiou Lab Supplies (distributor)
Nanopore sequencing: Novelty without compromise, Oxford Nanopore, Elta90MGR (distributor)
Nanopore sequencing: Novelty without compromise, Oxford Nanopore, Elta90MGR (distributor)
AI-Driven Molecular Prescreening in Digital Pathology: From Morphology to Molecular Signatures, Prof Dr Med Andreas Mamilos, German Medical Institute
AI-Driven Molecular Prescreening in Digital Pathology: From Morphology to Molecular Signatures, Prof Dr Med Andreas Mamilos, German Medical Institute
Mapping the Breakome in BRCA1/2 Mutation Carriers Reveals Early DNA Damage Landscapes in Breast Oncogenesis, Prof Rami Aqeilan, Cyprus Cancer Research Institute
Mapping the Breakome in BRCA1/2 Mutation Carriers Reveals Early DNA Damage Landscapes in Breast Oncogenesis, Prof Rami Aqeilan, Cyprus Cancer Research Institute
Cancer and adaptation: What is the evidence? Prof Konstantinos Voskarides, University of Nicosia
Cancer and adaptation: What is the evidence? Prof Konstantinos Voskarides, University of Nicosia
From basic research to pre-clinical studies, a 25-year journey Prof Constantinos Deltas, biobank.cy Center of Excellence, University of Cyprus
From basic research to pre-clinical studies, a 25-year journey Prof Constantinos Deltas, biobank.cy Center of Excellence, University of Cyprus
The CYPROME Genomics Platform: A Framework for Precision Medicine in Cyprus, Dr Apostolos Malatras, biobank.cy Center of Excellence, University of Cyprus
The CYPROME Genomics Platform: A Framework for Precision Medicine in Cyprus, Dr Apostolos Malatras, biobank.cy Center of Excellence, University of Cyprus
Treatment with 4-phenylbutyrate improves the kidney phenotype in a mouse model of Alport syndrome with a pathogenic variant in Col4a3. Dr Christoforos Odiatis, biobank.cy Center of Excellence, University of Cyprus
Treatment with 4-phenylbutyrate improves the kidney phenotype in a mouse model of Alport syndrome with a pathogenic variant in Col4a3. Dr Christoforos Odiatis, biobank.cy Center of Excellence, University of Cyprus
A digital kidney tubule twin for ADTKD-MUC1: Bridging multi-omics and mechanistic translation Dr Andrea Kakouri, biobank.cy Center of Excellence, University of Cyprus
A digital kidney tubule twin for ADTKD-MUC1: Bridging multi-omics and mechanistic translation Dr Andrea Kakouri, biobank.cy Center of Excellence, University of Cyprus
Advanced Therapies for Genetic Blood Disorders Dr Panayiota Papassava, The Cyprus Institute of Neurology and Genetics
Advanced Therapies for Genetic Blood Disorders Dr Panayiota Papassava, The Cyprus Institute of Neurology and Genetics
Emerging Therapeutic Approaches for Myotonic Dystrophy Type 1 Dr Andrie Koutsoulidou, The Cyprus Institute of Neurology and Genetics
Emerging Therapeutic Approaches for Myotonic Dystrophy Type 1 Dr Andrie Koutsoulidou, The Cyprus Institute of Neurology and Genetics
Gene therapies for rare neuromuscular disorders Dr Kleopas Kleopa, The Cyprus Institute of Neurology and Genetics
Gene therapies for rare neuromuscular disorders Dr Kleopas Kleopa, The Cyprus Institute of Neurology and Genetics
Bioinformatics Insights into Network Roadmaps Linking EBV to Multiple Sclerosis Dr George Spyrou, The Cyprus Institute of Neurology and Genetics
Bioinformatics Insights into Network Roadmaps Linking EBV to Multiple Sclerosis Dr George Spyrou, The Cyprus Institute of Neurology and Genetics
A synergistic approach for modulating the tumor microenvironment to improve therapeutic outcomes in cancer, Dr Fotios Mpekris, The Cyprus Institute of Neurology and Genetics
A synergistic approach for modulating the tumor microenvironment to improve therapeutic outcomes in cancer, Dr Fotios Mpekris, The Cyprus Institute of Neurology and Genetics
Breast cancer risk prediction Dr Kyriaki Michailidou, The Cyprus Institute of Neurology and Genetics
Breast cancer risk prediction Dr Kyriaki Michailidou, The Cyprus Institute of Neurology and Genetics
Molecular Pathways Driving the Transition from Dormancy to Colonization in Metastatic Breast Cancer, Dr Christiana Neophytou, European University Cyprus
Molecular Pathways Driving the Transition from Dormancy to Colonization in Metastatic Breast Cancer, Dr Christiana Neophytou, European University Cyprus
Liquid Biopsy-Guided Therapy Selection; Insights into Clinical Application in Cancer Dr Chrysa Soteriou, Medicover Genetics
Liquid Biopsy-Guided Therapy Selection; Insights into Clinical Application in Cancer Dr Chrysa Soteriou, Medicover Genetics
Prevalence and inheritance of susceptibility loci with incomplete penetrance and variable expressivity detected by prenatal and postnatal microarray testing, Dr Vasiliki Chini, Medicover Genetics
Prevalence and inheritance of susceptibility loci with incomplete penetrance and variable expressivity detected by prenatal and postnatal microarray testing, Dr Vasiliki Chini, Medicover Genetics
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M): Current Practices and Emerging Developments, Dr Thesallia Papasavva, The Cyprus Institute of Neurology and Genetics
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M): Current Practices and Emerging Developments, Dr Thesallia Papasavva, The Cyprus Institute of Neurology and Genetics
Refining Embryo Selection: Is Preimplantation Genetic Testing (PGT) enough? Ms Nicole Salameh, The Cyprus Institute of Neurology and Genetics
Refining Embryo Selection: Is Preimplantation Genetic Testing (PGT) enough? Ms Nicole Salameh, The Cyprus Institute of Neurology and Genetics
Optical genome mapping offers precise cytogenomic analysis and reproductive guidance for families with cryptic or complex chromosomal rearrangements Dr Constantia Aristidou, The Cyprus Institute of Neurology and Genetics
Optical genome mapping offers precise cytogenomic analysis and reproductive guidance for families with cryptic or complex chromosomal rearrangements Dr Constantia Aristidou, The Cyprus Institute of Neurology and Genetics
Importance of clinical interpretation in the era of massive genomic data, Dr Sophia Ourani, Makarios III Hospital
Importance of clinical interpretation in the era of massive genomic data, Dr Sophia Ourani, Makarios III Hospital
CSHG Board 2023-2025. From left to right: Dr Styliana Philippou, Dr Michaella Georgiadou, Dr Kyriaki Michailidou, Dr Marios Ioannides, Dr Skevi Kyriakou, Mr Panayiotis Myrianthopoulos and Dr Gregory Papagregoriou
CSHG Board 2023-2025. From left to right: Dr Styliana Philippou, Dr Michaella Georgiadou, Dr Kyriaki Michailidou, Dr Marios Ioannides, Dr Skevi Kyriakou, Mr Panayiotis Myrianthopoulos and Dr Gregory Papagregoriou